RT @CochraneJapan: COVID-19ウイルスへの感染を検出するための抗体検査の診断精度は? https://t.co/5hKxBaMDUs
RT @PaulGlasziou: V helpful Tweetorial summary of new systematic review of SARS-CoV-2 antibody tests: specificity 99%; sensitivity 80-90% -…
RT @Anibal_v_v: Pruebas de IgG/IgM para COVID-19 tuvieron una sensibilidad (verdaderos positivos) del 30% durante 1 a 7 días, 72% por 8 a 1…
Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library https://t.co/y8hJeZHWoU
RT @himmoderator: If you want to know about #covid19 #coronavirus #antibody testing then a @cochranecollab paper is the best place to go. B…
RT @NicoGagelmann: Another example that evidence synthesis is esp difficult in times of pandemia, defined by heterogeneity, reviews need to…
RT @NicoGagelmann: Another example that evidence synthesis is esp difficult in times of pandemia, defined by heterogeneity, reviews need to…
Another example that evidence synthesis is esp difficult in times of pandemia, defined by heterogeneity, reviews need to be living with protocols: Antibody tests for identification of current and past infection with #SARSCoV2 @CochraneLibrary https://t.
RT @veronicab1527: Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library ht…
Aquí un artículo científico excelente , que evidencia la poca “utilidad” de las pruebas rápidas. https://t.co/DI9uNJgYB9 Además, no creo que haya re infección, pero si mutación rápida del virus. ¡A cuidarnos! Saludos https://t.co/6UNE77oWro
@juancarlossaid Gracias. Complejo definir la utilidad de la prueba. Mayoría usa como GS PCR+, aquí captura de conclusiones https://t.co/8eqmKNknPw https://t.co/ikwkLgnFjj
Just published: Antibody tests for identification of current and past infection with SARS‐CoV‐2. Read this important @CochraneLibrary #COVID19 rapid review from @Cochrane_IDG. https://t.co/ruUz6Ffn7q https://t.co/hHqD7ro1Oq
Por lo tanto....
Pruebas de IgG/IgM para COVID-19 tuvieron una sensibilidad (verdaderos positivos) del 30% durante 1 a 7 días, 72% por 8 a 14 días, 91% por 15 a 21 días. No hay estudios sobre su utilidad más de los 35 días de síntomas, ni en casos leves o asintomáticos.htt
RT @destmauricemd: Cochrane Rev of #COVID19 serology "The sensitivity of Ab tests is too low in the 1st week since symptom onset to have a…
RT @veronicab1527: Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library ht…
RT @andern_sm: Sensibilidad de las pruebas rápidas según días de inicio de síntomas.. ahora tiene sentido que tantas personas salgan negati…
RT @veronicab1527: Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library ht…
RT @veronicab1527: Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library ht…
Mi protocolo personal: manejo a todos los pacientes como potenciales positivos, protejo a mi equipo quirúrgico y protejo a mis pacientes.
RT @ernestob: ¿Cuál es la precisión dca. de Ac para infección x COVID19?[Cochrane]➔Sensib ⇊baja en 1ª sem, dudoso papel principal en dco, s…
RT @tlassers: #CochraneEvidence in diagnosis of #COVID19. What we know now & what we need to know from a surging evidence base
RT @veronicab1527: Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library ht…
RT @chrishendel: Thanks for spotting this, @pash22 ! What is the diagnostic accuracy of #antibodytests for the detection of infection with…
RT @covid19maskjp: COVID-19ウイルスへの感染を検出するための抗体検査の診断精度は? https://t.co/zxgSjLS5Gx
RT @anna_thorson: Great summary review of antibody studies in this thread. Thank you @deeksj and colleagues! #SARSCoV2 #COVID19
RT @ernestob: ¿Cuál es la precisión dca. de Ac para infección x COVID19?[Cochrane]➔Sensib ⇊baja en 1ª sem, dudoso papel principal en dco, s…
1/3 Excellent summary re antibody tests I’ve had lots of discussions over the last few days & it’s really good to get this clarity that timing of test really matters & that we don’t know how well they work with people with mild disease @Airedale
RT @cochranecollab: #COVID19 | Led by Professor Jon Deeks @deeksj and @Cochrane_IDG this @CochraneLibrary review analysed worldwide data to…
Cochrane Rev of #COVID19 serology "The sensitivity of Ab tests is too low in the 1st week since symptom onset to have a primary role for the diagnosis of COVID‐19, but they may still have a role complementing other testing in individuals presenting later"
The significance of appropriate "timing" of #antibodytests for #SARSCoV2 becoming apparent yet it seems there's still lots to be learned prior to widespread utilisation #Cochrane Library https://t.co/WyI8gVXOmI
#antibodytest #boris #followthescience tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library https://t.co/I9HpvJY2cI
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
RT @HabibzadehMD: Sensitivity of #COVID19 #antibody testing very closely related to when the test is performed according to a recent @Coch…
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library https://t.co/oliHCcK8ax
RT @cochranecollab: #COVID19 | Led by Professor Jon Deeks @deeksj and @Cochrane_IDG this @CochraneLibrary review analysed worldwide data to…
RT @cochranecollab: JUST PUBLISHED - Antibody tests for identification of current and past infection with SARS‐CoV‐2 https://t.co/QTVoiTtDM…
RT @covid19maskjp: COVID-19ウイルスへの感染を検出するための抗体検査の診断精度は? https://t.co/zxgSjLS5Gx
RT @fascinatorfun: @devisridhar @SE25A Here is a Cochrane meta analysis/ review of serology tests and efficacy @devisridhar https://t.co/…
RT @CochraneJapan: COVID19の抗体検査の診断精度レビューが出版されました! 感度は非常に低く診断には有用でなさそうでした。一方、症状発症後15日以上経過しての使用は既感染の検出に有用な可能性が高いです。ただ、抗体の上昇期間は不明であり、症状発症後35日を…
RT @HelenRSalisbury: Really important thread on what we don't know about Covid19 antibodies and tests. Big issue for me is so many patients…
RT @emma_tj1: Great work. Demonstrating the need to evaluate the test in the community and longitudinally following onset of symptoms, to d…
RT @carpe_diem0820: SARS-CoV-2に対するIgG/IgM抗体の検査の感度は、発症から最初の1週間では30%、3週目で91%に上昇 発症後35日を超えるデータはほとんどないため、血清有病率調査に対する有用性は不明 Antibody tests for…
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
RT @DeirdreMunro: Diagnosis of acute suspected COVID‐19 in patients suspected COVID‐19 antibody tests have no role on their own as the prim…
Diagnosis of acute suspected COVID‐19 in patients suspected COVID‐19 antibody tests have no role on their own as the primary test when patients present during the first week since onset of symptoms as their sensitivity is too low via 2020 Cochrane Library
RT @JuanGrvas: IgG/IgM #tests. 1.000 people. [50 (5%) of them really had #COVID19] 58 test positive for #COVID19 [12 people (21%) false po…
RT @DrEmilyRSmith: Living systematic review thread re #COVID antibody tests below. As (good) systematic reviews can do — highlights where s…
Revisión sistemática Cochrane sobre Anticuerpos para Dx de infeccion por SARS-Cov-2: https://t.co/Qhp5yJtkAp https://t.co/wWvd4O6EMC
RT @HabibzadehMD: Sensitivity of #COVID19 #antibody testing very closely related to when the test is performed according to a recent @Coch…
RT @SaludBmanga: 🔗Systematic Review: Antibody Tests for Identification of Current and Past Infection with SARS‐CoV‐2 https://t.co/OklVaXhiSi
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
RT @ernestob: ¿Cuál es la precisión dca. de Ac para infección x COVID19?[Cochrane]➔Sensib ⇊baja en 1ª sem, dudoso papel principal en dco, s…
RT @JuanGrvas: IgG/IgM #tests. 1.000 people. [50 (5%) of them really had #COVID19] 58 test positive for #COVID19 [12 people (21%) false po…
RT @DrEmilyRSmith: Living systematic review thread re #COVID antibody tests below. As (good) systematic reviews can do — highlights where s…
RT @covid19maskjp: COVID-19ウイルスへの感染を検出するための抗体検査の診断精度は? https://t.co/zxgSjLS5Gx
RT @DrEmilyRSmith: Living systematic review thread re #COVID antibody tests below. As (good) systematic reviews can do — highlights where s…
RT @Laconic_doc: If you're wondering why there's been little news about antibody testing, it's because the studies checking test performanc…
RT @Laconic_doc: If you're wondering why there's been little news about antibody testing, it's because the studies checking test performanc…
If you're wondering why there's been little news about antibody testing, it's because the studies checking test performance have been very poor quality (& thus uncertain conclusions)... ...an excellent & authoritative thread summarizing current da
Follow this thread for an excellent summary of Cochrane evidence-based appraisal of antibody tests to diagnose #COVID19
RT @CochraneIberoam: 📢 ¡Nueva revisión de muuucho interés general! 👉 Pruebas de anticuerpos para la detección de la #covid19 (⚠️ La traducc…
Por quieren saber si la gripita o la calenturita de hace 15 días fue COVID 19, ya que en su momento les dio miedo o no pudieron pagar una RT-PCR (más cara y mas dolorosa☹️)
RT @DigitalSalud1: Revisión de la literatura relacionada con test rápidos 👇 "Antibody tests for identification of current and past infecti…
Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library https://t.co/oxBB5hsMfV
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
RT @ernestob: ¿Cuál es la precisión dca. de Ac para infección x COVID19?[Cochrane]➔Sensib ⇊baja en 1ª sem, dudoso papel principal en dco, s…
If you know folks who got COVID antibody tests done (like I do) show them this Cochrane paper - - useful only if done >15 days after symptom onset - very little data beyond 35 days - much uncertainty on antibody tests for ppl who were asymptomatic
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
RT @fascinatorfun: @devisridhar @SE25A Here is a Cochrane meta analysis/ review of serology tests and efficacy @devisridhar https://t.co/…
RT @JuanGrvas: IgG/IgM #tests. 1.000 people. [50 (5%) of them really had #COVID19] 58 test positive for #COVID19 [12 people (21%) false po…
Living systematic review thread re #COVID antibody tests below. As (good) systematic reviews can do — highlights where study design has gone wrong and lays bare high priority data gaps too. Designing/reviewing studies? Read this👇
RT @JeremyFarrar: Antibody tests for identification of current and past infection with SARS‐CoV‐2 - Deeks, JJ - 2020 | Cochrane Library htt…
Buena información https://t.co/2axDPW640R https://t.co/TPB3YZcXqr
RT @SaludBmanga: 🔗Systematic Review: Antibody Tests for Identification of Current and Past Infection with SARS‐CoV‐2 https://t.co/OklVaXhiSi
RT @AlvarezMorenoC: Ayer @CochraneLibrary publica una revisión sistemática del uso de pruebas rápidas serologicas (IgM, IgG) en #COVID19.…
🔗Systematic Review: Antibody Tests for Identification of Current and Past Infection with SARS‐CoV‐2 https://t.co/OklVaXhiSi